Skip to content

EFFECTIVENESS OF ARKAPUSHPA TAILA OVER SHATAPUSHPA TAILA NASYA IN ARTAVAKSHAYA WITH SPECIAL REFERENCE TO PCOD

A RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF ARKAPUSHPA TAILA OVER SHATAPUSHPA TAILA PRATIMARSHA NASYA IN ARTAVAKSHAYA WITH SPECIAL REFERENCE TO PCOD - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092299
Enrollment
40
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

Dr Akshata Paramagoudar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects between the age group of 18-35years irrespective of marital life. Subjects with Pratyatma lakshanas of Artavakshaya-Yatochit kala adarshanam,Alpa artavam,Yoni vedana. Subjects fulfilling the Rotterdam criteria.

Exclusion criteria

Exclusion criteria: Pregnancy and lactating women. Patients having systemic disorder like Anemia, HTN (uncontrolled), DM(uncontrolled) & Tuberculosis. Patients on OCP s or any other protocol of PCOD treatment. Patient with congenital uterine abnormalities & ovarian abnormality. Patient with other pelvic pathologies like genital TB, Benign and Malignant tumours. Endocrinal disorders Hyperprolactinemia, Thyroid abnormalities, Hypo/Hypergonadism and Pituitary Adenoma.

Design outcomes

Primary

MeasureTime frame
To prevent the reoccurrence of PCOD.Timepoint: 6 months.

Secondary

MeasureTime frame
To regularise the cycles.Timepoint: 6 months.

Countries

India

Contacts

Public ContactDr Niveditha Somalapur

Shree Jagadguru Gavisiddeshwara Ayurvedic Medical college and Hospital KOPPAL

nivedita.somalapur@gmail.com9886800413

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026